SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-017104
Filing Date
2020-06-18
Accepted
2020-06-18 17:29:31
Documents
1
Period of Report
2020-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11663
  Complete submission text file 0000899243-20-017104.txt   13560
Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Reporting) CIK: 0001534261 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39319 | Film No.: 20973652

Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 1140 NEW YORK NY 10019
Business Address
Casdin Eli (Reporting) CIK: 0001534264 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39319 | Film No.: 20973653

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Issuer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations